A Phase Ib study of Vyxeos® (liposomal daunorubicin and cytarabine) in combination with Clofarabine in children with relapsed/refractory AML
Promotor Name : Janssen
Investigator Name : M. ZWAAN
Trial registered on clinicaltrial.gov :